Patents Represented by Attorney Willard L. Cheesman
  • Patent number: 4080337
    Abstract: Multiheteromacrocycles are disclosed that contain as part of the macrocycle, assemblies of 2,6-dimethylylpyridine (and their corresponding amine oxides), 2,5-dimethylylfuran, 2,5-dimethylyltetrahydrofuran, Diels-Alder adducts of 2,5-dimethylylfuran (and their reduction products), 2- and 4-substituted 1,3-dimethylylbenzenes, pentamethylene, or p-phenylene coupled through oxygen to one another, or to ethylene, o-phenylene, or 1,1-binaphthyl-2,2- units (always coupled through oxygens) to form multidentate ligands for complexing selectively alkylammonium or metal cations.
    Type: Grant
    Filed: March 1, 1976
    Date of Patent: March 21, 1978
    Assignee: The Upjohn Company
    Inventor: Donald J. Cram
  • Patent number: 4018788
    Abstract: 6-(o-halophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepines of the following formula: ##STR1## wherein the substituent "Hal" is either of the halogens having an atomic number up to 35, inclusive, i.e., fluoro, chloro or bromo, and their pharmacologically acceptable acid addition salts which are especially useful as muscle relaxing and anxiolylic agents.
    Type: Grant
    Filed: December 24, 1975
    Date of Patent: April 19, 1977
    Assignee: The Upjohn Company
    Inventor: Jackson B. Hester, Jr.
  • Patent number: 4013688
    Abstract: Novel steroid derivatives containing a tyrosine ester amide group linked to an 11-hydroxysteroid alkylene dicarboxylic hemi-ester are described, suitable for iodination with radioactive iodine, useful in radioimmunoassay.
    Type: Grant
    Filed: December 20, 1972
    Date of Patent: March 22, 1977
    Assignee: The Upjohn Company
    Inventors: John C. Babcock, J. Allan Campbell
  • Patent number: 4001279
    Abstract: Chiral, hinged and functionalized host multiheteromacrocycles of the oxygen, nitrogen and sulfur-containing type are disclosed possessing holes sized to afford selective complexation of specific guest substances and shapes to recognize chirally guest molecules by virtue of the chiral steric barrier of the 2,2'-diheteroatom-1,1'-binaphthyl grouping, the naphthyl-naphthyl dihedral angle, and the provision of ortho positioned side chain substituents (arms) bearing terminal functional groups which act as counterions or additional complexing sites, and the provision of remote position side chain substituents used to control solubility and volatility properties or to bond the multiheteromacrocycles to solid supports.
    Type: Grant
    Filed: March 5, 1974
    Date of Patent: January 4, 1977
    Assignee: The Regents of the University of California
    Inventor: Donald J. Cram
  • Patent number: 3980638
    Abstract: Novel testosterone 17-ether 2,3-isoxazole and 2-cyano derivatives are disclosed as useful steroid enzyme inhibitors and for other pharmaceutical purposes.
    Type: Grant
    Filed: September 20, 1974
    Date of Patent: September 14, 1976
    Assignee: The Upjohn Company
    Inventors: John C. Babcock, J. Allan Campbell
  • Patent number: 3965116
    Abstract: Multiheteromacrocycles are disclosed that contain as part of the macrocycle, assemblies of 2,6-dimetylylpyridine (and their corresponding amine oxides), 2,5-dimethylylfuran, 2,5-dimethylyltetrahydrofuran, Diels-Alder adducts of 2,5-dimethylylfuran (and their reduction products), 2- and 4-substituted 1,3-dimethylylbenzenes, pentamethylene, or p-phenylene coupled through oxygen to one another or to ethylene, o-phenylene, or 1,1-binaphthyl-2,2- units (always coupled through oxygens) to form multidentate ligands for complexing selectively alkylammonium or metal cations.
    Type: Grant
    Filed: September 12, 1974
    Date of Patent: June 22, 1976
    Assignee: The Regents of the University of California
    Inventor: Donald J. Cram
  • Patent number: 3947520
    Abstract: Cis and trans isomers of 1,2-diphenyl-1,2,3,4-tetrahydronaphthalenes, novel processes for the preparation thereof, and novel intermediates are disclosed herein. The novel 1,2-diphenyl-1,2,3,4-tetrahydronaphthalenes have utility as antifertility estrogenic, anti-estrogenic, anti-spermatogenic, cholesterol lowering and lipid normalizing agents.
    Type: Grant
    Filed: December 5, 1974
    Date of Patent: March 30, 1976
    Assignee: The Upjohn Company
    Inventor: Daniel Lednicer